David A. Siegel Atri Cure, Inc. Transaction History

Two Sigma Advisers, LP

$42.8 Billion
Q1 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Atri Cure, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 658,300 shares of ATRC stock, worth $23.2 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

658,300

Previous 639,400 2.96%

Holding current value

$23.2 Million

Previous $19.5 Million 8.68%

% of portfolio

0.05%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$30.4 - $42.4 $574,560 - $801,360	18,900 Added 2.96%	658,300 $21.2 Million
Q4 2024 Feb 14, 2025	SELL	$27.02 - $38.2 $667,394 - $943,540	-24,700 Reduced 3.72%	639,400 $19.5 Million
Q3 2024 Nov 14, 2024	BUY	$20.34 - $29.5 $1.72 Million - $2.5 Million	84,700 Added 14.62%	664,100 $18.6 Million
Q2 2024 Aug 14, 2024	BUY	$19.86 - $29.09 $7.71 Million - $11.3 Million	388,400 Added 203.35%	579,400 $13.2 Million
Q1 2024 May 15, 2024	BUY	$28.21 - $37.78 $242,606 - $324,908	8,600 Added 4.71%	191,000 $5.81 Million
Q4 2023 Feb 14, 2024	SELL	$32.99 - $43.25 $1.88 Million - $2.47 Million	-57,000 Reduced 23.81%	182,400 $6.51 Million
Q3 2023 Nov 14, 2023	SELL	$41.12 - $57.73 $246,719 - $346,380	-6,000 Reduced 2.44%	239,400 $10.5 Million
Q2 2023 Aug 14, 2023	SELL	$40.44 - $49.6 $444,840 - $545,600	-11,000 Reduced 4.29%	245,400 $12.1 Million
Q1 2023 May 15, 2023	BUY	$35.87 - $47.22 $5.98 Million - $7.87 Million	166,600 Added 185.52%	256,400 $10.6 Million
Q4 2022 Feb 14, 2023	BUY	$33.48 - $47.45 $1.2 Million - $1.7 Million	35,800 Added 66.3%	89,800 $3.99 Million
Q3 2022 Nov 14, 2022	BUY	$38.25 - $52.62 $1.24 Million - $1.7 Million	32,300 Added 148.85%	54,000 $2.11 Million
Q2 2022 Aug 15, 2022	BUY	$35.1 - $66.01 $761,670 - $1.43 Million	21,700 New	21,700 $887,000
Q1 2022 May 16, 2022	SELL	$57.43 - $71.39 $402,010 - $499,730	-7,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$63.4 - $87.14 $3.84 Million - $5.27 Million	-60,500 Reduced 89.63%	7,000 $487,000
Q3 2021 Nov 15, 2021	BUY	$69.28 - $84.46 $2.91 Million - $3.55 Million	42,000 Added 164.71%	67,500 $4.7 Million
Q2 2021 Aug 16, 2021	BUY	$64.13 - $80.18 $1.64 Million - $2.04 Million	25,500 New	25,500 $2.02 Million
Q3 2020 Nov 16, 2020	SELL	$38.36 - $46.91 $3.91 Million - $4.78 Million	-101,800 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$31.78 - $51.19 $73,094 - $117,737	-2,300 Reduced 2.21%	101,800 $4.58 Million
Q1 2020 May 15, 2020	BUY	$24.49 - $43.84 $367,350 - $657,600	15,000 Added 16.84%	104,100 $3.5 Million
Q4 2019 Feb 14, 2020	SELL	$24.06 - $32.51 $1.07 Million - $1.45 Million	-44,600 Reduced 33.36%	89,100 $2.9 Million
Q3 2019 Nov 14, 2019	SELL	$23.81 - $32.52 $616,679 - $842,268	-25,900 Reduced 16.23%	133,700 $3.33 Million
Q2 2019 Aug 14, 2019	BUY	$26.85 - $30.74 $1.7 Million - $1.95 Million	63,400 Added 65.9%	159,600 $4.76 Million
Q1 2019 May 15, 2019	SELL	$26.38 - $33.34 $15,828 - $20,004	-600 Reduced 0.62%	96,200 $2.58 Million
Q4 2018 Feb 14, 2019	SELL	$26.66 - $34.85 $127,968 - $167,280	-4,800 Reduced 4.72%	96,800 $2.96 Million
Q3 2018 Nov 14, 2018	SELL	$27.62 - $35.58 $254,104 - $327,336	-9,200 Reduced 8.3%	101,600 $3.56 Million
Q2 2018 Aug 14, 2018	BUY	$19.65 - $30.28 $31,439 - $48,448	1,600 Added 1.47%	110,800 $3 Million
Q1 2018 May 15, 2018	BUY	$15.05 - $21.03 $15,050 - $21,030	1,000 Added 0.92%	109,200 $2.24 Million
Q4 2017 Feb 14, 2018	SELL	$17.69 - $23.44 $109,678 - $145,328	-6,200 Reduced 5.42%	108,200 $1.97 Million
Q3 2017 Nov 14, 2017	BUY	$20.0 - $24.23 $2.29 Million - $2.77 Million	114,400	114,400 $2.56 Million

Others Institutions Holding ATRC

# of Institutions

237

Shares Held

51.5M

Call Options Held

32.6K

Put Options Held

4.5K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.64B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account